Privacy Policy

FHL Therapeutics Website Privacy Policy


Forest Hills Partners (“us”, “we”, or “our”) operates https://fhltherapeutics.com/ (the “Website”).
We are committed to ensuring that your privacy is protected and this page informs you of our policies regarding the collection, use and disclosure of Personal Information we receive from users of the Website. If you are asked to provide information when using the Website, it will only be used in the ways described in this privacy policy.
By using the Site, you agree to the collection and use of information in accordance with this policy.



Information Collection


While using the Website, we may ask you to provide us with certain personally identifiable information. Personally identifiable information may include, but is not limited to your name, address, email address, contact number (“Personal Information”).
By using the Site, you agree to the collection and use of information in accordance with this policy.



Use of Information


We use this information in order to provide products and services, to enable certain functions on the Website and to understand your needs and provide you with a better service, and in particular for the following reasons:


• To complete order/s purchased via the Website, and to process your payments

• To improve our products and services we provide

• To customize the Website for you. Internal record keeping, and administrative purposes

• To contact you in response to specific enquiry



Cookies


Cookies are files with small amount of data, which may include an anonymous unique identifier. Cookies are sent to your browser from a web site and stored on your computer’s hard drive. Like many sites, we use “cookies” to collect information. You can instruct your browser to refuse all cookies or to indicate when a cookie is being sent. However, if you do not accept cookies, you may not be able to use some portions of our Site.



Security


The security of your Personal Information is important to us, but remember the internet is not a secure medium. However, we take reasonable technical and organizational precautions to prevent the loss, misuse or alteration of your personal information.



Changes to This Privacy Policy


This Privacy Policy is effective as of December 1, 2023 and will remain in effect except with respect to any changes in its provisions in the future, which will be in effect immediately after being posted on this page. We reserve the right to make changes to this privacy policy from time to time and you should check this Privacy Policy periodically. Your continued use of the Website after we post any modifications to the Privacy Policy on this page will constitute your acknowledgment of the modifications and your consent to abide and be bound by the modified Privacy Policy.



Contact Us


If you have any questions about this Privacy Policy, please contact us at +852 2155 0487 or email us at info@foresthillslab.com.

Terms & Conditions

FHL Therapeutics Website Privacy Policy


Forest Hills Partners (“FHP”) owns and operates this website (https://fhltherapeutics.com/). (This document governs your relationship with our website. These Terms and Conditions (the “Terms”) contained herein on this webpage, shall govern your use of the website, including all pages within this website (the “Website”). The Terms apply in full force and effect to your use of the Website and by accessing the Website, you agree to be bound by the Terms contained herein in full. You must not use the Website, if you disagree with any part of the Terms.



Age Restriction


You must be at least 18 years of age to use the Website; by using the Website or agreeing to the Terms, you warrant and represent to us that you are at least 18 years of age.



Intellectual Property Rights


The intellectual property rights in all software and content (including photographic images) made available to you on or through the Website remains the property of FHP or its licensors and are protected by copyright laws and treaties around the world. All such rights are reserved by FHP and its licensors. You may store, print and display the content supplied solely for your own personal use. You are not permitted to publish, manipulate, distribute or otherwise reproduce, in any format, any of the content or copies of the content supplied to you or which appears on the Website nor may you use any such content in connection with any business or commercial enterprise.



Coockies


Cookies are files with small amount of data, which may include an anonymous unique identifier. Cookies are sent to your browser from a web site and stored on your computer’s hard drive. Like many sites, we use “cookies” to collect information. You can instruct your browser to refuse all cookies or to indicate when a cookie is being sent. However, if you do not accept cookies, you may not be able to use some portions of our Site.



Prohibitions


You are expressly and emphatically restricted from all of the following: publishing any the Website material in any media; selling, sublicensing and/or otherwise commercializing any the Website material transmit or distribute a virus, trojan, worm, logic bomb or any other material which is malicious, technologically harmful, in breach of confidence or in any way offensive or obscene; using the Website in any way that impacts user access to the Website; engaging in any data mining, data harvesting, data extracting or any other similar activity in relation to the Website, or while using the Website; send any unsolicited advertising or promotional material, commonly referred to as “spam”;
Breaching this provision would constitute a criminal offense and FHP will report any such breach to the relevant law enforcement authorities and disclose your identity to them.
We will not be liable for any loss or damage caused by a distributed denial-of-service attack, viruses or other technologically harmful material that may infect your computer equipment, computer programs, data or other proprietary material due to your use of the Website or to your downloading of any material posted on it, or on any the website linked to it



No Warranties


The Website is provided “as is,” with all faults, and FHP makes no express or implied representations or warranties, of any kind related to the Website or the materials contained on the Website. Additionally, nothing contained on the Website shall be construed as providing consult or advice to you.



General Conditions


We reserve the right to refuse service to anyone for any reason at any time



Intellectual Property Rights


The intellectual property rights in all software and content (including photographic images) made available to you on or through the Website remains the property of FHP or its licensors and are protected by copyright laws and treaties around the world. All such rights are reserved by FHL and its licensors. You may store, print and display the content supplied solely for your own personal use. You are not permitted to publish, manipulate, distribute or otherwise reproduce, in any format, any of the content or copies of the content supplied to you or which appears on the Website nor may you use any such content in connection with any business or commercial enterprise.



Disclaimer of Liability


In no event shall FHP, nor any of its officers, directors and employees, be liable to you for anything arising out of or in any way connected with your use of the Website, whether such liability is under contract, tort or otherwise, and FHP including its officers, directors and employees shall not be liable for any indirect, consequential or special liability arising out of or in any way related to your use of the Website.



Indemnity


You agree to indemnify, defend and hold harmless FHP, its directors, officers, employees, consultants, agents, and affiliates, from and against any and all liabilities, costs, demands, causes of action, damages and expenses (including reasonable attorney’s fees) arising out of or in any way related to your breach of any of the provisions of the Terms.



Variation


FHP shall have the right in its absolute discretion at any time and without notice to amend, remove or vary the Website and/or any page of the Website. You should check this page regularly to take notice of any changes we may have made to the Terms.



Invalidity


If any provision of the Terms is found to be unenforceable or invalid under any applicable law, such unenforceability or invalidity shall not render the Terms unenforceable or invalid as a whole, and such provisions shall be deleted without affecting the remaining provisions herein.



Complaints


We operate a complaint handling procedure which we will use to try to resolve disputes when they first arise, please let us know if you have any complaints or comments through +852 2155 0487 or info@foresthillslab.com.



Waiver


If you breach these conditions and we take no action, we will still be entitled to use our rights and remedies in any other situation where you breach the Terms.



Entire Agreement


The above terms, including any legal notices and disclaimers contained on the Website, constitute the entire agreement of the parties and supersede any and all preceding and contemporaneous agreements between you and FHP, and supersede all prior agreements and understandings with respect to the same.

Press Releases
News
Forest Hills Lab Expands Pipeline and Readies for Clinical Development

2022.08.22

HONG KONG, S.A.R., August 22, 2022 /EINPresswire.com/ -- Forest Hills Lab (FHL) is an innovative regenerative medicine company seeking to improve the quality of life of our rapidly aging society. FHL’s Neuro-Med division, which is a therapeutic drug development platform focused on neurodegenerative diseases, today announces the expansion of its pipeline and updates to its clinical development programs.

The FHL pipeline has been expanded from two to eight candidates. This expansion reflects the fact that neurodegenerative diseases such as Parkinson’s and Alzheimer’s disease are heterogenous and will likely require multiple approaches for effective treatment. The expanded pipeline also supports FHL’s platform business model to enable the company to rapidly develop its candidates and form strategic alliances with multiple partners to accelerate the pipeline’s development. The pipeline candidates today encompass various disease-modifying mechanisms of action, and both new and refocused drugs. Aside from oral delivery, multiple candidates have also shown promising preclinical data when intranasally delivered, which may enable more efficient delivery past the blood brain barrier.

Multiple candidates of FHL’s pipeline were licensed from Dr. Kalipada Pahan’s lab at Rush University. Pahan, who is also on FHL’s Scientific Advisory Board, said, “We are excited to continue our partnership with Forest Hills Lab to bring our lab’s discoveries to neurodegenerative disease patients in need. These candidates showed effects including a reduction of alpha-synuclein and amyloid-beta levels in Parkinson’s and Alzheimer’s animal models, respectively. We are hopeful that these effects will translate well during clinical development.”

Additionally, FHL is preparing for clinical development for several of its pipeline programs. FHL-301 is a refocused drug that is preparing to proceed into Phase II trials for Parkinson’s disease patients. FHL-101 is a New Chemical Entity which has recently received Investigational New Drug approval to proceed with Phase I trial while FHL-201 is also nearing readiness to initiate Phase I studies.

“We are proud that FHL has made excellent progress entering clinical development for our lead drug candidate soon after another drug candidate was cleared to commence Phase 2 trial last year. Parkinson’s and Alzheimer’s disease represent an extraordinary burden to patients and society at large. We are hopeful that FHL’s therapies may become effective, patient-friendly, disease-modifying treatments in the near future,” said Alex Yang, Chair of the Board and Chief Executive Officer of Forest Hills Lab.


About Forest Hills Lab
Forest Hills Lab is an innovative regenerative medicine company seeking to improve the quality of life of our rapidly aging society. FHL is comprised of two divisions: Neuro-Med and Cos-Med. FHL’s Neuro-Med division is a therapeutic drug development platform focused on neurodegenerative diseases with high unmet need. FHL’s Cos-Med division develops and markets a comprehensive line of aesthetics products globally.

Forest Hills Lab’s largest shareholder is Mstone Partners, an entrepreneurial biotech incubator in the form of a holding company which owns and manages a portfolio of drug development companies. Mstone focuses on pediatric and repurposed drugs, rare and neurodegenerative diseases, and innovative technologies for targeted indications. Since its inception in 2016, Mstone has invested in two US and one HK company, which are now in advanced clinical-stages with the US FDA. Mstone has also established a number of portfolio companies under the Curestone Platform, which manages a portfolio of drug development companies in a centralized, hub-and-spoke model.

For more information, please visit https://foresthillslab.com/.

 

List